Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592461 · ClinicalTrials.gov registry record
Starting Treatment With Agonist Replacement Therapies Follow-up Study
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 877
- Enrollment target
NCT01592461 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 877 participants.
The verdict
NCT01592461 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 877 participants
- Enrollment target
Study Summary
The purpose of the study is to conduct a follow-up of substance abuse patients (n=1,269) about 2 to 5 years since they were originally recruited from 8 substance abuse treatment clinics (located in 5 states) to participate in a prior clinical trial study called "START" (Starting Treatment with Agonist Replacement Therapies). The START Follow-up Study will be conducted over 5 years and will involve three follow-up interviews with START participants. The specific aims of the START Follow-up Study are as follows. 1. To determine longer-term outcomes of Suboxone versus methadone treatment received in the START 2. To investigate patient and treatment factors associated with post-START treatment access, utilization, and outcomes among Suboxone and methadone patients 3. To explore other correlates of the long-term outcomes among START patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 877 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01592461
The ClinicalTrials.gov registry entry for NCT01592461 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 877 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01592461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01592461 about?
NCT01592461 is a clinical study titled "Starting Treatment With Agonist Replacement Therapies Follow-up Study". The purpose of the study is to conduct a follow-up of substance abuse patients (n=1,269) about 2 to 5 years since they were originally recruited from 8 substance abuse treatment clinics (located in 5 states) to participate in a prior clinical trial study called "START" (Starting Treatment with Agoni...
What is the current status of trial NCT01592461?
This trial is currently completed. The enrollment target is 877 participants. The study started on 2010-09. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01592461?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.